QLYS insider notice: 1,287 vested shares proposed for sale via Charles Schwab

Rhea-AI Filing Summary

Qualys, Inc. (QLYS) submitted a Form 144 indicating a proposed sale of 1,287 common shares through Charles Schwab on Nasdaq, with an aggregate market value reported as $169,951 and total shares outstanding of 36,095,879. The securities were acquired as vested restricted stock grants on 06/12/2020 and the filing lists a payment classification of equity compensation dated 06/12/2024. The sale is scheduled approximately for 08/13/2025.

This quantity represents about 0.0036% of the outstanding shares, indicating the proposed sale is immaterial to overall share capital. The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: A small, routine insider sale of vested equity; immaterial to capitalization and unlikely to move the stock.

The filing shows a proposed disposition of 1,287 shares valued at $169,951, equal to roughly 0.0036% of outstanding shares (36,095,879 reported). The shares were acquired via vested restricted stock grants on 06/12/2020 with payment characterized as equity compensation. No sales were reported in the prior three months. Given the negligible percentage of float, this is a routine liquidity event rather than a material corporate development.

Corporate Governance Expert

TL;DR: Routine insider liquidity with standard Form 144 disclosures and the usual certification about material nonpublic information.

The notice records a broker (Charles Schwab) and an approximate sale date (08/13/2025). The filer affirms they do not possess undisclosed material adverse information and the form allows for disclosure of any Rule 10b5-1 trading plan adoption, though no such plan date is shown. This filing reads as a standard compliance disclosure for sale of vested restricted stock and poses no obvious governance concern on its face.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp 3000 Schwab Way Westlake TX 76262	1287	169951.00	36095879	08/13/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/12/2020	Vested Restricted Stock Grants	Issuer			1287	06/12/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Qualys (QLYS) Form 144 disclose?

The filing discloses a proposed sale of 1,287 common shares via Charles Schwab on Nasdaq with aggregate value $169,951 and approx sale date 08/13/2025.

How were the shares acquired that are being sold in the QLYS Form 144?

The securities were acquired as vested restricted stock grants on 06/12/2020 and payment is listed as equity compensation dated 06/12/2024.

How large is the proposed sale relative to Qualys' outstanding shares?

The 1,287 shares represent about 0.0036% of the reported 36,095,879 shares outstanding, indicating a very small impact on capitalization.

Does the Form 144 show any other recent sales by the filer?

No. The filing states Nothing to Report for securities sold during the past three months.

Which broker will handle the proposed sale in the QLYS Form 144?

The broker named in the filing is Charles Schwab Corp, 3000 Schwab Way, Westlake TX 76262.